Company Tagline
Advancing our proprietary Axiomer™ RNA-editing platform technology
Industry Category
Business Keywords
Company Description
ProQR Therapeutics is dedicated to transforming lives through pioneering biotechnology research. Specializing in advancing the proprietary Axiomer™ RNA-editing platform technology, ProQR Therapeutics focuses on developing innovative solutions for genetic and rare diseases. With a commitment to making a meaningful impact, ProQR Therapeutics combines cutting-edge technologies and entrepreneurial spirit to address critical healthcare challenges.
Located at Zernikedreef 9, Leiden, Zuid-Holland 2333CK, NL, and with an additional location at 245 Main St, 2nd Floor, Cambridge, Massachusetts 02142, US, ProQR Therapeutics is strategically positioned to foster collaboration and innovation. The company's focus on RNA therapeutics, orphan drugs, and pharmaceuticals underscores its dedication to developing effective treatments for unmet medical needs.
ProQR Therapeutics continues to expand its capabilities and broaden its impact within the biotechnology sector. The company is committed to driving advancements in drug development and RNA editing to improve patient outcomes. We invite the management team at ProQR Therapeutics to create a customized and exclusive company showcase and product listing on our platform to further highlight your achievements and innovations.
ProQR Therapeutics s'engage à transformer des vies grâce à la recherche biotechnologique pionnière. Spécialisée dans l'avancement de la technologie exclusive de plateforme d'édition d'ARN Axiomer™, ProQR Therapeutics se concentre sur le développement de solutions innovantes pour les maladies génétiques et rares. Avec un engagement à avoir un impact significatif, ProQR Therapeutics combine des technologies de pointe et un esprit d'entreprise pour relever les défis critiques en matière de soins de santé.
Située à Zernikedreef 9, Leiden, Zuid-Holland 2333CK, NL, et avec un emplacement supplémentaire au 245 Main St, 2nd Floor, Cambridge, Massachusetts 02142, US, ProQR Therapeutics est stratégiquement positionnée pour favoriser la collaboration et l'innovation. L'accent mis par l'entreprise sur les thérapies à base d'ARN, les médicaments orphelins et les produits pharmaceutiques souligne son engagement à développer des traitements efficaces pour les besoins médicaux non satisfaits.
ProQR Therapeutics continue d'étendre ses capacités et d'élargir son impact dans le secteur de la biotechnologie. L'entreprise s'engage à faire progresser le développement de médicaments et l'édition d'ARN afin d'améliorer les résultats pour les patients. Nous invitons l'équipe de direction de ProQR Therapeutics à créer une vitrine d'entreprise et une liste de produits personnalisées et exclusives sur notre plateforme afin de mettre davantage en valeur vos réalisations et vos innovations.
Key Personnel / Employees
Compare Companies Side by Side
Compare ProQR Therapeutics with 3 companies in Biotechnology-Research
| Comparison Field |
ProQR TherapeuticsMain Company |
RecordatiView Profile |
Pharma BPView Profile |
Morgan Prestwich - L...View Profile |
|---|---|---|---|---|
|
Founded Year
|
— | 0 | 2015 | 2010 |
|
Company Size
|
— | 1,001-5,000 | 2-10 | 11-50 |
|
City
|
Leiden, Zuid-Holland | Milan, Italy | Not Specified, Dubai | Reigate, Surrey |
|
Country
|
Netherlands | Italy | United Arab Emirates | United Kingdom |
|
Skills & Keywords
Comparing with main company
|
12 Total Skills
Biotechnology
RNA Therapeutics
Drug Development
Genetic Diseases
Orphan Drugs
RNA Editing
Pharmaceuticals
Drug development
RNA therapeutics
Orphan drugs
RNA editing
Rare Diseases
|
4 Total
4 Unique
Unique Skills:
Chemicals
Commercialisation & Licensing
Industrial Operations
Specialty & Primary Care
|
11 Total
1 Common
10 Unique
Match
8%
Common Skills:
Orphan Drugs
Unique Skills:
Africa
Cell Therapies
GCC
Gene Therapies
Healthcare
Market Access
+4
|
54 Total
1 Common
53 Unique
Match
8%
Common Skills:
Biotechnology
Unique Skills:
Biotech
Biotech Recruitment
Biotechnology Recruitment
Boards
Business Development
Cell Therapy
+47
|
4
Total Companies2010
Oldest Founded4
Countries78
Unique SkillsSimilar Companies
Other organizations in the same industry
mimiX Biotherapeutics
Biotechnology-ResearchNext Generation Biofabrication - Sound Induced Morphogenesis //Acoustic biofabrication
Nospharma
Biotechnology-ResearchInnovating Treatments for Rare Neurological Disorders
Australian Centre for Precision Health and Technol...
Biotechnology-ResearchImproving health through disruptive technologies.
Alternative Company Names
This company is also known as